Hjem › Steatotisk leversykdom › Missouri
Kliniske studier for Steatotisk leversykdom i Missouri
14 studier for Steatotisk leversykdom søker deltakere på steder i Missouri.
Byer i Missouri
Offisiell studietekst (engelsk)
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, St Louis
- 89bio Clinical Study Site, St Louis
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 5. okt. 2026 · NCT06419374A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, St Louis
RekruttererFase 3
Alder 18 til 80 · Alle kjønn · Oppdatert 5. okt. 2026 · NCT06318169A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GSK Investigational Site, St Louis
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07704892A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GSK Investigational Site, St Louis
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07701993A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
- Washington University School of Medicine, St Louis
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT05519475A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- AMR Clinical, Kansas City
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07165028A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Columbia
- Akero Clinical Study Site, Kansas City
- Akero Clinical Study Site, St Louis
- og 1 flere
RekruttererFase 3
Alder 18 til 80 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT06528314A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
- GSK Investigational Site, Springfield
- GSK Investigational Site, St Louis
- GSK Investigational Site, St Louis
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07221188A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Gastrointestinal Associates, Columbia
- Gateway GI Research, LLC, St Louis
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07288138Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)
- University of Missouri School of Medicine, Columbia
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 18 til 70 · Alle kjønn · Oppdatert 6. aug. 2026 · NCT06571474Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity
- University of Missouri School of Medicine, Columbia
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 18 til 70 · Alle kjønn · Oppdatert 6. aug. 2026 · NCT06335771A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
- GSK Investigational Site, Kansas City
- GSK Investigational Site, Springfield
- GSK Investigational Site, St Louis
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 27. jul. 2026 · NCT07221227A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
- GSK Investigational Site, Kansas City
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 8. jul. 2026 · NCT06920043Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans
- Harry S. Truman Memorial, Columbia, MO, Columbia
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 19. feb. 2026 · NCT05526144Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.